Pulmonary Outcomes in Pediatric Sickle Cell Disease Following Myeloablative Hematopoietic Stem Cell Transplantation

Key Points

• Improved pulmonary outcomes observed after hematopoietic stem cell transplantation in children with sickle cell disease.
• A notable percentage experienced reduced respiratory complications, showing the significance of intervention.
• Assessment involved evaluating lung function pre- and post-transplant among pediatric patients.
• This work highlights important findings but requires further validation across diverse patient groups.